Pharmaceuticals
-
Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer of Sanofi
Jun 13, 2019At Sanofi‘s meeting on June 6th of 2019, Sanofi’s Board of Directors unanimously appointed Paul Hudson as Chief Executive Officer of the Group, to succeed Olivier Brandicourt who has decided to retire. The Board of Directors would... -
Marie-France Tschudin becomes the new leader of Pharmaceuticals Business Unit of Novartis
Jun 13, 2019Novartis announced that Marie-France Tschudin, currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed President, Novartis Pharmaceuticals. She will report to Vas Narasimhan, CEO Novartis, and will join the Executive Committee with immediate... -
Novartis to buy dry-eye drug Xiidra from Takeda Pharmaceutical Co
May 9, 2019Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal, announced early on Thursday, calls for... -
Alcon announces the acquisition of PowerVision
Mar 19, 2019Alcon, a division of Novartis, announced that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating... -
Novartis announces offer to acquire CellforCure
Dec 24, 2018Novartis announced an offer to acquire CellforCure from LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO) producing cell and gene therapies in Europe. Under the proposed... -
Novartis announced Susanne Schaffert as CEO of Novartis Oncology
Dec 24, 2018Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on... -
Europe granted marketing authorization for dengue vaccine Dengvaxia ®
Dec 24, 2018The European Commission has granted marketing authorization for Dengvaxia®, Sanofi‘s dengue vaccine. The marketing authorization follows the October 18, 2018, recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to approve... -
Praava Health inaugurates model pharmacy in Dhaka
Dec 16, 2018The inauguration and ribbon cutting ceremony of Praava Health’s model pharmacy took place at on Thursday, December 13, 2018, in Banani, Dhaka. The ceremony was led by Ms. Sylvana Q. Sinha, Founder, Managing Director, & CEO,... -
Roche’s Tecentriq wins priority review from US FDA for treating lung cancer
Dec 5, 2018Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has... -
Pfizer’s blood cancer drug approved by FDA
Nov 22, 2018The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc’s drug to treat a form of blood cancer in newly diagnosed patients as a combination therapy. Pfizer plans to launch the drug, Daurismo, in the...
